Recommended clinical indications: Control of hypothyroidism, congenital hypothyroidism in infants , acquired hypothyroidism in children and juvenile myxoedema.
Recommended clinical indications: Control of hypothyroidism, congenital hypothyroidism in infants, acquired hypothyroidism in children and juvenile myxoedema.
Insys Therapeutics, Inc. a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, announced...
The FDA has approved Epidiolex (cannabidiol) [CBD] oral solution ,from GW Pharma and Greenwich Biosciences, for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.
Eton Pharmaceuticals, Inc and Azurity Pharmaceuticals, Inc. announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.